The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Sourcing · Regulatory

Import rules for personal quantities, by jurisdiction, dated

MD
m.duarteTL2 Moderator28 Mar 2025#1

On the subject in the title: Import rules for personal quantities, by jurisdiction, dated Working notes rather than a conclusion.

Structured report rather than an opinion, following the format the maintainers asked for.

  • Compound: semaglutide
  • Independent testing: VendorInvestigate
  • Method as reported: reversed-phase HPLC, 220 nm
  • Result: 95.9% area
  • Certificate figure for the same lot: 99.2%

I am not drawing a conclusion about the supplier from one lot and I would ask that nobody else does either. I am adding a data point to a record.

0 likes 16mo
FN
f.novakTL2 Moderator15 May 2025#2

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

0 likes 14mo
BR
buffer_reviewTL3Regular19 Jun 2025#3

post #2 answers the question as asked. The question underneath it is different.

Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict and vary by jurisdiction. Generalising from one country's rules to another's is unreliable.

4 likes 13mo
AN
a.norgaardTL2 Moderator19 Jul 2025#4

Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal use depends on your country's rules, not on where it is sold.

12 likes 12mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Enforcement priorities versus written rules — does this still hold?
Enforcement priorities versus written rules — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion, following…
ROOSOCDSV+36 40 37k 11mo
Pharmaceutical compounding rules, summarised from primary sources
Pharmaceutical compounding rules, summarised from primary sources — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the…
BJMBEDRIIL+135 163 46k 17mo
Research-use-only labelling: what it means and what it does not
Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not Everything below is what sits behind that. I would like to talk about documentation quality as a…
ZNPPJENGGR+100 110 37k 5mo
How compounding permissions changed when supply normalised
Asking directly, because I could not find a straight answer: How compounding permissions changed when supply normalised Structured report rather than an opinion, following the format the maintainers asked…
GCCCCCMEMP+30 34 51k 16mo
Prescription requirements and telehealth models
Prescription requirements and telehealth models Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than anywhere…
MBNHKDWV+91 97 5.4k 7mo

Related topics — sharing the tags compounding, MHRA, FDA

TopicParticipantsRepliesViewsActivity
Official shortage notices and what they authorise
Posting this under the heading it deserves: Official shortage notices and what they authorise Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…
AVPPNSNGRM+106 119 18k 1mo
MHRA statements, read directly
MHRA statements, read directly Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what determines the…
VMSOGHTVJ+93 101 2.2k 5mo
NHS criteria and how they are applied in practice
NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines…
AEUCRVTPAV+37 42 31k 2d
Why a compound being unapproved is not the same as being illegal to possess
Why a compound being unapproved is not the same as being illegal to possess I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion,…
LCFNJBSCAN+72 78 23k 3mo
List price versus negotiated price versus what you pay
On the subject in the title: List price versus negotiated price versus what you pay Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires.…
JPJAVFVBCA+99 115 11k 3mo